| Field | Specification |
|---|---|
| UniProt # | |
| Applications | |
| Sensitivity | |
| Detection range | |
| Detection method | |
| Assay time | |
| Storage | |
| Shipping | |
| Catalog no. (Mfr.) | |
| Main SKU |
Scientific Background
This ELISA kit applies to the in vitro quantitative determination of Human PDGF-BB concentrations in serum, plasma and other biological fluids.
Assay Principle
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human PDGF-BB. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human PDGF-BB and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human PDGF-BB, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human PDGF-BB. You can calculate the concentration of Human PDGF-BB in the samples by comparing the OD of the samples to the standard curve.
Performance Specifications
| Sensitivity | 18.75 pg/mL |
|---|---|
| Detection Range | 31.25-2000 pg/mL |
| Total Assay Time | 3 h 30 min |
| Compatible Sample Types | Serum, plasma and other biological fluids |
| Species Reactivity | Human |
| Detection Method | Sandwich |
| Precision (CV) | Both intra-CV and inter-CV are < 10%. |
| Recovery Rate | 80%-120% |
| Storage | 2-8℃,12 months |
✓ Research-Grade Validation
Specificity
This kit recognizes Human PDGF-BB in samples. No significant cross-reactivity or interference between Human PDGF-BB and analogues was observed
Safety & Regulatory
Handle reagents in accordance with institutional biosafety guidelines. Refer to the Safety Data Sheet (SDS) for complete hazard and handling information. Contains components that may require special disposal procedures per local regulations.
This kit is validated for use with Serum, plasma and other biological fluids. For unlisted matrices (e.g., tissue lysate, urine), perform a spike-and-recovery experiment to confirm assay performance before generating reportable data. Sample dilution in the kit's provided diluent is recommended to minimize matrix interference.
The minimum detectable concentration (sensitivity) of this kit is 18.75 pg/mL. Values below this threshold should be reported as below the limit of detection (<LOD) and should not be extrapolated from the standard curve.
The total assay time from sample addition to absorbance reading is approximately 3 h 30 min, including all incubation, wash, and substrate steps. Hands-on time is typically 1–2 hours; most steps involve passive plate incubation. Plan the assay as a single uninterrupted session for best results.
Standard components of this Sandwich ELISA Kit typically include: pre-coated microplate (96-well strip format), lyophilized or liquid recombinant PDGF-BB standard, detection antibody, streptavidin-HRP conjugate, TMB substrate, stop solution, wash buffer concentrate, and sample/standard diluent. Refer to the kit insert or datasheet for the exact component list and storage requirements.
This kit uses colorimetric (TMB/HRP) detection and requires a standard microplate absorbance reader capable of measuring at 450 nm. A reference wavelength of 570 nm or 630 nm is recommended to reduce background. No specialized fluorescence or luminescence reader is needed. Ensure the instrument is calibrated and the plate is clean and free of condensation before reading.
Tissue samples may contain endogenous or exogenous proteases during processing, leading to degradation of extracted proteins. Therefore, it's necessary to add protease inhibitors during processing to ensure the integrity of target proteins. If customers can keep samples cold and handle them quickly during processing, omitting the protease inhibitor may not have a significant effect. After preparation, samples should be tested promptly or immediately aliquoted and frozen at -20°C or -80°C.
What is the range of enzyme activity of your IL-2 freeze-dried powder
What is the principle of adding stop solution to stop color reaction in ELISA experiment?
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Regulation of macrophage subtype via injectable micro/nano-structured porous microsphere for reprogramming osteoimmune microenvironment (2022) CHEMICAL ENGINEERING JOURNAL. 10.1016/j.cej.2022.135692
Biomimetic Triplet Messenger RNA Formulation in MXene Hydrogel Microneedles for Wound Healing (2024) Aggregate. 10.1002/agt2.700
Ligand-Selective Targeting of Macrophage Hydrogel Elicits Bone Immune-Stem Cell Endogenous Self-Healing Program to Promote Bone Regeneration (2024) Advanced Healthcare Materials. 10.1002/adhm.202303851
Self-Assembled Peptide Hydrogels Loaded with Umbilical Cord-Derived Mesenchymal Stem Cells Repairing Injured Endometrium and Restoring Fertility (2024) Advanced Healthcare Materials. 10.1002/adhm.202400524
Janus adhesive microneedle patch loaded with exosomes for intrauterine adhesion treatment (2024) Journal of Materials Chemistry B. 10.1039/D3TB03036A
A collagen scaffold loaded with human umbilical cord-derived mesenchymal stem cells facilitates endometrial regeneration and restores fertility (2019) Acta Biomaterialia. 10.1016/j.actbio.2019.05.012
GP IIb/IIIa-ICAM-1 Mediated Platelet-Endothelial Adhesion Exacerbates Pulmonary Hypertension (2025) AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY. 10.1165/rcmb.2024-0438OC
Cytokine concentration in peripheral blood of patients with childhood obesity (2025) Frontiers in Immunology. 10.3389/fimmu.2025.1606375
MicroRNA-432-5p regulates sprouting and intussusceptive angiogenesis in osteosarcoma microenvironment by targeting PDGFB (2021) LABORATORY INVESTIGATION. 10.1038/s41374-021-00589-3
Genkwanin enhances survival of rat random skin flap: promoting autophagic flux by modulation of AMPK/TSC2/mTOR signaling pathway through SIRT1 (2026) BIOCHEMICAL PHARMACOLOGY. 10.1016/j.bcp.2026.117797
An engineered human placental organoid microphysiological system in a vascular niche to model viral infection (2025) Communications Biology. 10.1038/s42003-025-08057-0
Influence of periodontitis and diabetes on structure and cytokine content of platelet-rich fibrin (2022) ORAL DISEASES. 10.1111/odi.14275
Effects of a PDGF-Stem Cell-Hydrogel Compound on Skin Wound Healing in Mice (2025) CYTOTHERAPY. 10.1016/j.jcyt.2025.01.001
Advanced platelet-rich fibrin promotes the paracrine function and proliferation of adipose-derived stem cells and contributes to micro-autologous fat transplantation by modulating HIF-1α and VEGF (2022) Annals of Translational Medicine. 10.21037/atm-21-6812
Autologous Blood Clot Therapy for Wounds: Investigating the Chemotactic Effect on PBMCs and Fibroblasts in Diabetes (2026) WOUND REPAIR AND REGENERATION. 10.1111/wrr.70153
The therapeutic effect of sufficient oxygen-rich PRP injection in facial rejuvenation by multiple objective evaluations in 26 cases (2024) Regenerative Therapy. 10.1016/j.reth.2024.05.013
Long-term stability of frozen platelet-rich plasma under??80?°C storage condition (2024) Regenerative Therapy. 10.1016/j.reth.2024.09.006
Prevention of Intrauterine Adhesion with Platelet-Rich Plasma Double-Network Hydrogel (2024) Advanced Biology. 10.1002/adbi.202400336
Ampelopsin E Reduces the Invasiveness of the Triple Negative Breast Cancer Cell Line, MDA-MB-231 (2019) MOLECULES. 10.3390/molecules24142619
Comparison of growth factor levels in injectable platelet-rich fibrin obtained from healthy individuals and patients with chronic periodontitis: a pilot study (2024) BMC Oral Health. 10.1186/s12903-024-04301-x
Human Colon Cancer HT29 Cell Line Treatment with High-Dose LAscorbic Acid Results to Reduced Angiogenic Proteins Expression and Elevated Pro-apoptotic Proteins Expression (2023) CURRENT MOLECULAR MEDICINE. 10.2174/1566524022666220616141725
Platelet-derived growth factor-BB is A novel inflammatory biomarker of No-Reflow in STEMI patients treated with primary PCI (2025) JOURNAL OF THROMBOSIS AND THROMBOLYSIS. 10.1007/s11239-025-03191-2
Comparison of Cytokine Profile between Postmenopausal Women with and Without Osteoporosis – A Case-Control Study (2023) Endocrine Metabolic & Immune Disorders-Drug Targets. 10.2174/1871530323666221114111029
Leukocyte depletion does not affect the in?vitro healing ability of platelet rich plasma (2018) Experimental and Therapeutic Medicine. 10.3892/etm.2018.5887
Detecting Novel Urine Biomarkers for the Early Diagnosis of Prostate Cancer: Platelet Derived Growth Factor-BB as a Possible New Target (2018) Current Urology. 10.1159/000447225
